Sofgen Pharma

Sofgen Pharma Inventory

The Inventory of Sofgen Pharma (PROCF) as of Oct 19, 2026 is 76.54 M USD. In the previous year, Inventory was 101.83 M USD — a change of -24.83% (lower).

Inventory

76.54 MUSD

YoY

-24.83%

Last updated:

Inventory of Sofgen Pharma is 2024 76.54 M USD. Inventory of Sofgen Pharma was 2023 101.83 M USD. It decreases by -24.83% lower compared to the previous year.

The Sofgen Pharma Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2020
64.30 M USD
Jan 1, 2021
81.56 M USD
Jan 1, 2022
99.76 M USD
Jan 1, 2023
101.83 M USD
Jan 1, 2024
76.54 M USD
The Sofgen Pharma Inventory history
YEARInventoryYoY
76.54 MUSD-24.83%
101.83 MUSD+2.07%
99.76 MUSD+22.32%
81.56 MUSD+26.84%
64.30 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sofgen Pharma Stock analysis

What does Sofgen Pharma do? Sofgen Pharma SA, listed under the ticker PROCF with ISIN LU2376511205, is a pharmaceutical company headquartered in Luxembourg. The company operates within the Health Care sector, specifically in the Pharmaceuticals industry. Sofgen Pharma employs approximately 5,500 people and completed its initial public offering on December 9, 2019. The company's website is https://www.procapsgroup.com/. Sofgen Pharma SA develops, manufactures, and sells prescription drugs and products featuring unique combinations and pharmaceutical forms, alongside nutritional supplements such as omega-3 fish oils and high-potency clinical compounds. The company organizes its operations through five business units: Diabetrics, Farma Procaps, Softi Gel, Vital Care, and Clinical Specialties. Diabetrics focuses on diabetes solutions. Farma Procaps is involved in formulating, manufacturing, and marketing branded prescription drugs in Latin America. Softi Gel offers contract drug development and manufacturing services to other pharmaceutical companies. Vital Care specializes in developing, manufacturing, and marketing consumer healthcare products. Clinical Specialties is dedicated to the development, manufacturing, and marketing of complex drugs. The company's business model emphasizes specialized pharmaceutical solutions and consumer health products, with a global operational footprint. Sofgen Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sofgen Pharma stock

Inventory of Sofgen Pharma is 76.54 M USD in 2024.

Inventory of Sofgen Pharma changed from 101.83 M USD to 76.54 M USD, representing a -24.83% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Inventory Sofgen Pharma since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Sofgen Pharma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Sofgen Pharma

All Key Metrics — Sofgen Pharma